Alseres Pharmaceuticals Inc De (ALSE) SEC Filing 10-K Annual report for the fiscal year ending Friday, December 31, 2010

Alseres Pharmaceuticals Inc De

CIK: 94784 Ticker: ALSE

View differences made from one year to another to evaluate Alseres Pharmaceuticals Inc De's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Alseres Pharmaceuticals Inc De.


Assess how Alseres Pharmaceuticals Inc De's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Alseres Pharmaceuticals Inc De's Definitive Proxy Statement (Form DEF 14A) filed after their 2011 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: ALSE
CIK: 94784
Form Type: 10-K Annual Report
Accession Number: 0000950123-11-031417
Submitted to the SEC: Thu Mar 31 2011 3:07:05 PM EST
Accepted by the SEC: Thu Mar 31 2011
Period: Friday, December 31, 2010
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: